AAPL310.66-2.00 (-0.64%) ▼|ABBV254.65-0.11 (-0.04%) ▼|ABT95.84+0.21 (+0.22%) ▲|ACN142.14+5.18 (+3.78%) ▲|ADBE221.54+3.47 (+1.59%) ▲|AMAT554.50-38.29 (-6.46%) ▼|AMD516.11-35.94 (-6.51%) ▼|AMGN368.10+1.66 (+0.45%) ▲|AMT165.25+3.14 (+1.94%) ▲|AMZN245.98+1.82 (+0.75%) ▲|AVGO370.78-3.12 (-0.83%) ▼|AXP349.58-6.45 (-1.81%) ▼|BA231.68-2.86 (-1.22%) ▼|BAC59.86-0.04 (-0.07%) ▼|BKNG181.95+0.92 (+0.51%) ▲|BLK1,009.43-1.78 (-0.18%) ▼|BMY57.97+1.27 (+2.24%) ▲|BNY152.91+2.95 (+1.97%) ▲|BRK-B504.00-2.58 (-0.51%) ▼|C140.77-3.09 (-2.15%) ▼|CAT940.12-29.80 (-3.07%) ▼|CL95.03+1.64 (+1.76%) ▲|CMCSA23.41+0.03 (+0.13%) ▲|COF202.89-3.61 (-1.75%) ▼|COP108.44+4.86 (+4.69%) ▲|COST947.50-2.75 (-0.29%) ▼|CRM169.52+3.87 (+2.34%) ▲|CSCO111.79-2.19 (-1.92%) ▼|CVS104.33+2.25 (+2.20%) ▲|CVX174.01+5.91 (+3.52%) ▲|DE603.61-31.63 (-4.98%) ▼|DHR194.19+0.57 (+0.29%) ▲|DIS97.48+0.07 (+0.07%) ▲|DUK128.22+2.25 (+1.79%) ▲|EMR137.91-3.65 (-2.58%) ▼|FDX312.88+2.95 (+0.95%) ▲|GD374.64-2.24 (-0.59%) ▼|GE366.98-11.70 (-3.09%) ▼|GEV1,077.08-74.96 (-6.51%) ▼|GILD136.36+6.75 (+5.21%) ▲|GM76.03-1.82 (-2.34%) ▼|GOOG363.62-1.28 (-0.35%) ▼|GOOGL367.03+0.57 (+0.16%) ▲|GS1,042.98-12.31 (-1.17%) ▼|HD345.21-5.44 (-1.55%) ▼|HON225.05-6.13 (-2.65%) ▼|IBM306.13+6.61 (+2.21%) ▲|INTC110.39-11.81 (-9.66%) ▼|INTU281.17+9.03 (+3.32%) ▲|ISRG427.30-5.53 (-1.28%) ▼|JNJ267.24+7.91 (+3.05%) ▲|JPM339.22+1.50 (+0.44%) ▲|KO84.05+1.09 (+1.31%) ▲|LIN538.23-2.29 (-0.42%) ▼|LLY1,235.56+35.50 (+2.96%) ▲|LMT535.38-2.62 (-0.49%) ▼|LOW220.90-2.88 (-1.29%) ▼|LRCX326.13-24.07 (-6.87%) ▼|MA531.62-1.48 (-0.28%) ▼|MCD282.21+2.71 (+0.97%) ▲|MDLZ60.22+1.05 (+1.77%) ▲|MDT83.83+0.77 (+0.93%) ▲|META615.58+15.29 (+2.55%) ▲|MMM158.01-1.14 (-0.72%) ▼|MO72.96+1.08 (+1.50%) ▲|MRK128.86+2.08 (+1.64%) ▲|MS222.04-0.06 (-0.03%) ▼|MSFT388.84+2.10 (+0.54%) ▲|MU938.38-46.37 (-4.71%) ▼|NEE88.47+1.03 (+1.18%) ▲|NFLX76.18+0.16 (+0.21%) ▲|NKE43.21-0.13 (-0.30%) ▼|NOW110.73+2.80 (+2.59%) ▲|NVDA196.93+1.38 (+0.71%) ▲|ORCL141.60-2.16 (-1.50%) ▼|PEP144.98+1.69 (+1.18%) ▲|PFE24.07+0.35 (+1.48%) ▲|PG152.75+3.44 (+2.30%) ▲|PLTR134.37+1.83 (+1.38%) ▲|PM187.79+3.03 (+1.64%) ▲|QCOM182.97-3.51 (-1.88%) ▼|RTX200.85-0.52 (-0.26%) ▼|SBUX103.61+1.50 (+1.47%) ▲|SCHW101.93+1.31 (+1.30%) ▲|SO97.29+1.30 (+1.35%) ▲|SPG227.19+2.19 (+0.97%) ▲|T21.09+0.51 (+2.48%) ▲|TMO516.62-0.98 (-0.19%) ▼|TMUS184.73+2.94 (+1.62%) ▲|TSLA402.90-16.87 (-4.02%) ▼|TXN293.30-10.20 (-3.36%) ▼|UBER74.33+1.91 (+2.64%) ▲|UNH428.19+10.20 (+2.44%) ▲|UNP283.12+0.53 (+0.19%) ▲|UPS111.96+1.94 (+1.76%) ▲|USB62.89+0.06 (+0.10%) ▲|V352.20-5.05 (-1.41%) ▼|VZ42.59+0.52 (+1.24%) ▲|WFC87.18-0.27 (-0.31%) ▼|WMT111.54+0.89 (+0.80%) ▲|XOM141.69+5.25 (+3.85%) ▲|AAPL310.66-2.00 (-0.64%) ▼|ABBV254.65-0.11 (-0.04%) ▼|ABT95.84+0.21 (+0.22%) ▲|ACN142.14+5.18 (+3.78%) ▲|ADBE221.54+3.47 (+1.59%) ▲|AMAT554.50-38.29 (-6.46%) ▼|AMD516.11-35.94 (-6.51%) ▼|AMGN368.10+1.66 (+0.45%) ▲|AMT165.25+3.14 (+1.94%) ▲|AMZN245.98+1.82 (+0.75%) ▲|AVGO370.78-3.12 (-0.83%) ▼|AXP349.58-6.45 (-1.81%) ▼|BA231.68-2.86 (-1.22%) ▼|BAC59.86-0.04 (-0.07%) ▼|BKNG181.95+0.92 (+0.51%) ▲|BLK1,009.43-1.78 (-0.18%) ▼|BMY57.97+1.27 (+2.24%) ▲|BNY152.91+2.95 (+1.97%) ▲|BRK-B504.00-2.58 (-0.51%) ▼|C140.77-3.09 (-2.15%) ▼|CAT940.12-29.80 (-3.07%) ▼|CL95.03+1.64 (+1.76%) ▲|CMCSA23.41+0.03 (+0.13%) ▲|COF202.89-3.61 (-1.75%) ▼|COP108.44+4.86 (+4.69%) ▲|COST947.50-2.75 (-0.29%) ▼|CRM169.52+3.87 (+2.34%) ▲|CSCO111.79-2.19 (-1.92%) ▼|CVS104.33+2.25 (+2.20%) ▲|CVX174.01+5.91 (+3.52%) ▲|DE603.61-31.63 (-4.98%) ▼|DHR194.19+0.57 (+0.29%) ▲|DIS97.48+0.07 (+0.07%) ▲|DUK128.22+2.25 (+1.79%) ▲|EMR137.91-3.65 (-2.58%) ▼|FDX312.88+2.95 (+0.95%) ▲|GD374.64-2.24 (-0.59%) ▼|GE366.98-11.70 (-3.09%) ▼|GEV1,077.08-74.96 (-6.51%) ▼|GILD136.36+6.75 (+5.21%) ▲|GM76.03-1.82 (-2.34%) ▼|GOOG363.62-1.28 (-0.35%) ▼|GOOGL367.03+0.57 (+0.16%) ▲|GS1,042.98-12.31 (-1.17%) ▼|HD345.21-5.44 (-1.55%) ▼|HON225.05-6.13 (-2.65%) ▼|IBM306.13+6.61 (+2.21%) ▲|INTC110.39-11.81 (-9.66%) ▼|INTU281.17+9.03 (+3.32%) ▲|ISRG427.30-5.53 (-1.28%) ▼|JNJ267.24+7.91 (+3.05%) ▲|JPM339.22+1.50 (+0.44%) ▲|KO84.05+1.09 (+1.31%) ▲|LIN538.23-2.29 (-0.42%) ▼|LLY1,235.56+35.50 (+2.96%) ▲|LMT535.38-2.62 (-0.49%) ▼|LOW220.90-2.88 (-1.29%) ▼|LRCX326.13-24.07 (-6.87%) ▼|MA531.62-1.48 (-0.28%) ▼|MCD282.21+2.71 (+0.97%) ▲|MDLZ60.22+1.05 (+1.77%) ▲|MDT83.83+0.77 (+0.93%) ▲|META615.58+15.29 (+2.55%) ▲|MMM158.01-1.14 (-0.72%) ▼|MO72.96+1.08 (+1.50%) ▲|MRK128.86+2.08 (+1.64%) ▲|MS222.04-0.06 (-0.03%) ▼|MSFT388.84+2.10 (+0.54%) ▲|MU938.38-46.37 (-4.71%) ▼|NEE88.47+1.03 (+1.18%) ▲|NFLX76.18+0.16 (+0.21%) ▲|NKE43.21-0.13 (-0.30%) ▼|NOW110.73+2.80 (+2.59%) ▲|NVDA196.93+1.38 (+0.71%) ▲|ORCL141.60-2.16 (-1.50%) ▼|PEP144.98+1.69 (+1.18%) ▲|PFE24.07+0.35 (+1.48%) ▲|PG152.75+3.44 (+2.30%) ▲|PLTR134.37+1.83 (+1.38%) ▲|PM187.79+3.03 (+1.64%) ▲|QCOM182.97-3.51 (-1.88%) ▼|RTX200.85-0.52 (-0.26%) ▼|SBUX103.61+1.50 (+1.47%) ▲|SCHW101.93+1.31 (+1.30%) ▲|SO97.29+1.30 (+1.35%) ▲|SPG227.19+2.19 (+0.97%) ▲|T21.09+0.51 (+2.48%) ▲|TMO516.62-0.98 (-0.19%) ▼|TMUS184.73+2.94 (+1.62%) ▲|TSLA402.90-16.87 (-4.02%) ▼|TXN293.30-10.20 (-3.36%) ▼|UBER74.33+1.91 (+2.64%) ▲|UNH428.19+10.20 (+2.44%) ▲|UNP283.12+0.53 (+0.19%) ▲|UPS111.96+1.94 (+1.76%) ▲|USB62.89+0.06 (+0.10%) ▲|V352.20-5.05 (-1.41%) ▼|VZ42.59+0.52 (+1.24%) ▲|WFC87.18-0.27 (-0.31%) ▼|WMT111.54+0.89 (+0.80%) ▲|XOM141.69+5.25 (+3.85%) ▲|
21.1 C
New York
Tuesday, July 7, 2026

Tag: risk

MountBay Energy Unlocks Microbial Biofilm Technology to Revolutionize Battery Longevity

NEW YORK, June 21, 2025 (GLOBE NEWSWIRE) -- MountBay Energy has unveiled groundbreaking research on microbial biofilms that could redefine the future of grid-scale energy storage. The study, led by founder Vrushabhraj Tanawade, introduces a bio-integrated insulation method using thermophilic and mesophilic microbial consortia to regulate heat inside battery modules. The results are striking: up to a 22% reduction in internal temperature and a 30% improvement in carbon lifecycle efficiency.

Analyzing Annuities’ Reputation: Evaluating Their Role in Strategic Financial Planning

Running out of money in retirement is a significant concern among investors, often surpassing even the fear of death. While maximizing contributions to an...

Analyzing U.S. Tech Dominance: Quantifying Potential Strategic Shifts Impacting European Markets

Microsoft's compliance with a U.S. executive order led to the suspension of the email account of an International Criminal Court (ICC) prosecutor investigating alleged...

The China Fund, Inc. Announces Board Approval of Plan of Liquidation

BOSTON, June 20, 2025 (GLOBE NEWSWIRE) -- The China Fund, Inc. (NYSE: CHN) (the “Fund”) announced today that its Board of Directors (the “Board”) has approved a plan of liquidation and dissolution (the “Plan”) for the Fund. The Plan will be submitted to Fund stockholders for approval at a Special Meeting. The date of the Special Meeting and more detailed information about the proposed liquidation and Plan will be set forth in a proxy statement to be mailed to the Fund’s stockholders in the near future. The Board recommends that the Fund’s stockholders vote for the liquidation of the Fund at the Special Meeting.

Saudi Arabia Concludes Landmark BIO 2025 Debut as Kingdom Opens Doors to Global Biotech Collaboration

From genomics to regulatory innovation, the Kingdom’s presence in Boston establishes it as a major partner in global health science
From genomics to regulatory innovation, the Kingdom’s presence in Boston establishes it as a major partner in global health science

Enzon and Viskase Enter into Merger Agreement

Enzon and Viskase stockholders will respectively own approximately 15.9% and 84.1% of the combined company
Enzon and Viskase stockholders will respectively own approximately 15.9% and 84.1% of the combined company

Novo Nordisk: Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third achieving 25% or more...

Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third achieving 25% or more – according to data presented at ADA

Novo Nordisk advances early-stage obesity medication, amycretin, to phase 3 clinical development based on early-phase clinical trial results in people with obesity or excess...

Both subcutaneous and oral formulations will advance straight to phase 3 development based on completed clinical studies and feedback received from regulatory authorities1,2PLAINSBORO, N.J.,...

New Research on Abbott’s Healthy Food Rx Program Shows ‘Food is Medicine’ Approach Helps People Living With Diabetes Eat Better and Feel Healthier

Randomized, controlled clinical trial presented as a late-breaking poster at ADA's Scientific Sessions shows people participating in Abbott's Healthy Food Rx ate more vegetables and...

Stem Cell-Derived Islet Therapies Shown to Reduce the Need for Injectable Insulin

Breakthrough Studies Demonstrate Stem Cell-Based Technologies as a Potential Alternative Treatment for Type 1 Diabetes CHICAGO, June 20, 2025 /PRNewswire/ -- Findings from two studies...

Novel Artificial Intelligence Models Detect Type 1 Diabetes Risk Before Clinical Onset

New Studies Highlight Machine Learning as Potential Early Risk Detection Strategy CHICAGO, June 20, 2025 /PRNewswire/ -- Developments from two studies highlighting the potential for machine...

Parkland Corporation Announces Execution of Supplemental Indentures for Senior Notes in Connection with the Consent Solicitations

CALGARY, AB, June 20, 2025 /PRNewswire-HISPANIC PR WIRE/ -- Parkland Corporation (TSX: PKI) ("Parkland") today announced that in connection with the successful completion of...

INVESTOR NOTICE: Apple Inc. (AAPL) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Robbins Geller

SAN DIEGO, June 20, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Apple Inc. (NASDAQ: AAPL) securities between June 10, 2024 and June 9, 2025, inclusive (the “Class Period”), have until August 19, 2025 to seek appointment as lead plaintiff of the Apple class action lawsuit. Captioned Tucker v. Apple Inc., No. 25-cv-05197 (N.D. Cal.), the Apple class action lawsuit charges Apple and certain of Apple’s top current and former executives with violations of the Securities Exchange Act of 1934.

Parkland Corporation Announces Execution of Supplemental Indentures for Senior Notes in Connection with the Consent Solicitations

CALGARY, AB, June 20, 2025 /PRNewswire/ - Parkland Corporation (TSX: PKI) ("Parkland") today announced that in connection with the successful completion of its previously...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRisk